Company intelligence / Profile preview

ENEA

Rome, Italy

Ownership: Private
Employees: ~40
Development stage: Other

Overview

ENEA Tech and Biomedical Foundation acts as an economic and strategic catalyst in Italy for technology transfer, investing in and developing startups and platforms in cell/gene therapy, diagnostics, and precision medicine; several portfolio assets are in clinical or near-commercial phases

Therapeutic areas: CardiovascularNeurologyRare DiseasesOtherOncology
Modalities: Cell therapyGene therapyMedical deviceDiagnostic technologySmall moleculeDigital healthOther
Industry: Investors

Partnerships

Approxima (MedTech investment)Tethis (Oncology diagnostics)Ri.MED Foundation (strategic biomedical R&D partnership)Indaco Venture Partners (co-investor in portfolio companies)Panakès Partners (co-investor)Various Italian universities and spin-offs

Beyond the preview

Go deeper on ENEA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ENEA.

Explore the full profile